Natural Product: NPC50228

Natural Product IDNPC50228
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Mezzettiaside 9
IUPAC Name [(2S,3S,4S,5R,6R)-4-[(2S,3R,4R,5S,6S)-3,4-diacetyloxy-5-hydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-2-methyl-6-octoxyoxan-3-yl] hexanoate
Synonyms Mezzettiaside 9
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL443164
PubChem CID 10054386
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0003909] Fatty Acyls
        • [CHEMONTID:0001766] Fatty acyl glycosides
          • [CHEMONTID:0003861] Fatty acyl glycosides of mono- and disaccharides

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey RDCMFBVGEZABQK-UWVAMOTESA-N
Standard InCHI InChI=1S/C30H52O12/c1-7-9-11-12-13-15-17-36-29-24(35)27(25(19(4)38-29)41-22(33)16-14-10-8-2)42-30-28(40-21(6)32)26(39-20(5)31)23(34)18(3)37-30/h18-19,23-30,34-35H,7-17H2,1-6H3/t18-,19-,23-,24+,25-,26+,27-,28+,29+,30-/m0/s1
SMILES CCCCCCCCO[C@H]1[C@@H]([C@@H]([C@H]([C@H](C)O1)OC(=O)CCCCC)O[C@H]1[C@@H]([C@@H]([C@H]([C@H](C)O1)O)OC(=O)C)OC(=O)C)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   604.35 Volume:   607.896
?
Van der Waals volume.
Dense:   0.994 LogP:   3.815
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.747
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.596
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   20.0 Rigid Bonds:   15.0
TPSA:   156.28
?
Topological Polar Surface Area.
H-Bond Acceptor:   12.0
H-Bond Donor:   2.0 Rings:   2.0
Heavy Atoms:   12.0

MedChem Properties

QED Drug-Likeness Score:   0.142 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.57 Fsp3:   0.9
MCE-18:   44.667
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.803 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.006
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.002
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.311 Promiscuous compounds:   0.302

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.355 MDCK Permeability:   -4.962
Pgp-inhibitor:   0.602 Pgp-substrate:   0.992
PAMPA:   0.604
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.792
20% Bioavailability (F20%):   0.836 30% Bioavailability (F30%):   0.949
50% Bioavailability (F50%):   0.987

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.001 MRP1:   0.995
Plasma Protein Binding (PPB):   90.153% Volume Distribution (VD):   0.23
Fu: 9.498%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.652
OATP1B3 inhibitor:   0.974 BCRP inhibitor:   0.094
BSEP inhibitor:   0.979

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.997
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.324
CYP2C9-inhibitor:   0.001 CYP2C9-substrate:   0.428
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.151
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.994
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  3.82 Half-life (T1/2):  1.006

ADMET: Toxicity

hERG Blockers:  0.057 hERG Blockers (10um):  0.354
Human Hepatotoxicity (H-HT):  0.328 Drug-induced Liver Injury (DILI):  0.808
AMES Toxicity:  0.427 Rat Oral Acute Toxicity:  0.091
Maximum Recommended Daily Dose:  0.006 Skin Sensitization:  0.998
Carcinogencity:  0.035 Eye Corrosion:  0.202
Eye Irritation:  0.605 Respiratory Toxicity:  0.063
Drug-induced Neurotoxicity:  0.002 Ototoxicity:  0.78
Hematotoxicity:  0.414 Drug-induced Nephrotoxicity:  0.331
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.092
A549 Cytotoxicity:  0.6 Hek293 Cytotoxicity:  0.092
BCF:   0.682
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.093
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.628
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.734
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO25657 Mezzettia leptopoda Species Annonaceae Eukaryota n.a. n.a. n.a. PMID[9868159]
NPO25657 Mezzettia leptopoda Species Annonaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1034 Cell line Lu1 Homo sapiens ED50 = 5.4 ug ml-1 PMID[16933888]
NPT1851 Cell line Col2 Homo sapiens ED50 > 20.0 ug ml-1 PMID[25815139]
NPT91 Cell line KB Homo sapiens ED50 = 11.3 ug ml-1 PMID[9599261]
NPT91 Cell line KB Homo sapiens ED50 > 20.0 ug ml-1 PMID[18177011]
NPT858 Cell line LNCaP Homo sapiens ED50 > 20.0 ug ml-1 PMID[22409377]
NPT91 Cell line KB Homo sapiens ED50 = 19.0 uM PMID[21080703]
NPT1034 Cell line Lu1 Homo sapiens ED50 = 9.0 uM PMID[19738007]
NPT397 Cell line NCI-H460 Homo sapiens IC50 = 151000.0 nM PMID[12617583]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. ED50 > 20.0 ug ml-1 PMID[25729554]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. ED50 > 20.0 uM PMID[25729554]
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC = 16000.0 nM PMID[15050621]
NPT19 Organism Escherichia coli Escherichia coli MIC > 32000.0 nM PMID[10785413]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 32000.0 nM PMID[8254344]
NPT175 Organism Enterococcus faecalis Enterococcus faecalis MIC = 32000.0 nM DrugMatrix in vitro pharmacology data
NPT1531 Organism Enterococcus faecium Enterococcus faecium MIC > 32000.0 nM DrugMatrix in vitro pharmacology data

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC50228 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8103 Intermediate Similarity NPC39266
0.807 Intermediate Similarity NPC211428
0.75 Intermediate Similarity NPC225748
0.746 Intermediate Similarity NPC9763
0.7385 Intermediate Similarity NPC169085
0.7377 Intermediate Similarity NPC97736
0.6269 Remote Similarity NPC52268
0.6197 Remote Similarity NPC53760
0.5797 Remote Similarity NPC67099
0.5606 Remote Similarity NPC471761

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC50228 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data